H股发行上市
Search documents
浙江海亮股份有限公司 第九届董事会第六次会议决议公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2026-01-08 23:04
登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码:002203 证券简称:海亮股份 公告编号:2026-001 浙江海亮股份有限公司 第九届董事会第六次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确、完整,没有虚假记载、误导性陈述或重大遗 漏。 浙江海亮股份有限公司(以下简称"公司")第九届董事会第六次会议通知于2026年1月6日以电子邮件、 电话传真或送达书面通知的方式发出,会议于2026年1月7日下午在浙江省杭州市滨江区协同路368号海 亮科研大厦公司会议室召开,本次会议以现场表决和通讯表决相结合方式召开,会议应到董事九名,实 到董事九名,公司高级管理人员列席本次会议。本次会议由董事长冯橹铭先生主持。 本次会议出席人数、召开程序、议事内容均符合《中华人民共和国公司法》和《浙江海亮股份有限公司 章程》的规定,决议合法有效。 经全体董事认真审阅并在议案表决书上表决签字,会议审议通过了如下议案: 一、审议通过了《关于修订公司于H股发行上市后适用的〈公司章程(草案)〉及相关议事规则(草 案)的议案》 董事会同意根据《中华人民共和国公司法》《境内企业境外发行证券和上市管理试行办法》《香港 ...
用友网络科技股份有限公司关于发行H股并上市的进展公告
Shang Hai Zheng Quan Bao· 2025-12-29 18:41
鉴于本次发行并上市的认购对象仅限于符合相关条件的境外投资者及依据中国相关法律法规有权进行境 外证券投资的境内合格投资者,公司将不会在境内证券交易所的网站和符合境内监管机构规定条件的媒 体上刊登该申请资料,但为使境内投资者及时了解该等申请资料披露的本次发行并上市以及公司的其他 相关信息,现提供该申请资料在香港联交所网站的查询链接供查阅: 中文: 登录新浪财经APP 搜索【信披】查看更多考评等级 股票简称:用友网络 股票代码:600588 编号:临2025-092 用友网络科技股份有限公司 关于发行H股并上市的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容 的真实性、准确性和完整性承担个别及连带责任。 用友网络科技股份有限公司(以下简称"公司")正在进行申请境外公开发行股票(H股)并在香港联合 交易所有限公司(以下简称"香港联交所")主板上市(以下简称"本次发行")的相关工作。公司已于 2025年6月27日向香港联交所递交了本次发行的申请,并于同日在香港联交所网站刊登了本次发行的申 请资料。 根据公司发行计划及香港联交所的相关要求,公司于2025年12月29日 ...
澜起科技:拟H股全球发售上市,向核心高管授股1140万股
Xin Lang Cai Jing· 2025-12-26 11:19
澜起科技公告称,第三届董事会第十三次会议审议多项议案。同意首次公开发行H股及在港交所上市相 关安排,授权处理发行上市具体事务;结合实际情况,同意修订H股发行上市后生效的公司章程。此 外,鉴于授予条件已成就,公司将以2025年某日为授予日,45.91元/股的价格,向2名激励对象授予新 增的1140万股限制性股票,董事杨崇和、Stephen Kuong - Io Tai回避表决。 ...
上市进程稳步推进,豪威集团刊发H股发行聆讯后资料集
Ju Chao Zi Xun· 2025-12-17 13:53
Core Viewpoint - The announcement by the company indicates significant progress in the H-share issuance and listing process on the Hong Kong Stock Exchange, with key milestones achieved in the application and approval stages [2] Group 1: H-Share Issuance Progress - On June 27, 2025, the company submitted its application for H-share issuance and published the relevant application materials to the Hong Kong Stock Exchange [2] - On December 9, 2025, the company received a notification from the China Securities Regulatory Commission confirming the registration of the overseas issuance and listing [2] - A listing hearing was held by the Hong Kong Stock Exchange Listing Committee on December 11, 2025, to review the company's application for H-share issuance [2] Group 2: Compliance and Information Disclosure - The published post-hearing information set is prepared in accordance with the requirements of the Hong Kong Stock Exchange and the Securities and Futures Commission of Hong Kong [2] - The purpose of the publication is to provide relevant information to the public and qualified investors in Hong Kong [2]
新国都向香港联交所递交H股发行上市申请并刊发申请资料
Zhi Tong Cai Jing· 2025-11-26 00:33
Core Viewpoint - The company, New Guodu (300130), has submitted an application for issuing overseas listed shares (H shares) and listing on the main board of the Hong Kong Stock Exchange on November 25, 2025 [1] Group 1 - The application for H shares listing has been officially filed with the Hong Kong Stock Exchange [1] - The application materials for this issuance and listing have been published on the Hong Kong Stock Exchange's website on the same day [1]
沃尔核材:H股发行上市有益于公司的长远发展
Zheng Quan Ri Bao· 2025-11-24 09:07
Core Viewpoint - The company believes that the issuance and listing of H-shares will benefit its long-term development by enhancing financing channels and supporting ongoing investments in technology research, capacity construction, and overseas market expansion [2]. Group 1 - The H-share issuance will help the company broaden its financing channels [2]. - It will provide strong support for continuous investment in technology research, capacity construction, and overseas market layout [2]. - The move is expected to enhance the company's core competitiveness [2]. Group 2 - The H-share issuance will facilitate the company's internationalization strategy [2]. - It aims to improve the company's international brand image [2]. - The company will consider various factors to reasonably arrange related work [2].
广东领益智造股份有限公司 关于向香港联交所递交H股发行上市申请并刊发申请资料的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-21 00:35
Core Viewpoint - Guangdong Lingyi Intelligent Manufacturing Co., Ltd. has submitted an application for the issuance of H-shares and listing on the Hong Kong Stock Exchange, indicating a strategic move to access international capital markets [1][2]. Group 1: Application Details - The application for the H-share issuance was submitted on November 20, 2025, and the related materials were published on the Hong Kong Stock Exchange website on the same day [1]. - The issuance will be limited to qualified overseas investors and domestic qualified investors who are authorized to conduct overseas securities investments under Chinese laws [1][2]. Group 2: Regulatory Considerations - The issuance and listing are subject to approvals from the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange, indicating that the process involves multiple regulatory layers [2]. - The company will not publish the application materials on domestic stock exchange websites or media, but will provide links for domestic investors to access the information on the Hong Kong Stock Exchange website [1][2].
苏州纳芯微电子股份有限公司关于刊发H股发行聆讯后资料集的公告
Shang Hai Zheng Quan Bao· 2025-11-19 18:42
Core Viewpoint - Suzhou Naxin Microelectronics Co., Ltd. is in the process of applying for the issuance of H-shares and listing on the Hong Kong Stock Exchange, with the necessary documentation submitted and regulatory approvals pending [1][5]. Group 1: Application Process - The company submitted its application for H-share issuance and listing to the Hong Kong Stock Exchange on April 25, 2025, and published the application materials on the same day [2]. - On October 27, 2025, the company resubmitted its application to the Hong Kong Stock Exchange and published the updated application materials [2]. - The company received a confirmation from the China Securities Regulatory Commission regarding the filing for overseas issuance and listing on October 21, 2025 [3]. Group 2: Listing Hearing and Information Disclosure - A listing hearing was held by the Hong Kong Stock Exchange Listing Committee on October 30, 2025, to review the company's application for issuance and listing [4]. - The company published a post-hearing information package on the Hong Kong Stock Exchange website, which is intended to provide information to the public and qualified investors [4]. - The company will not publish the post-hearing information package on domestic stock exchange websites but will provide links for A-share investors to access the information [4]. Group 3: Regulatory Approvals - The issuance and listing are subject to final approvals from the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, indicating that there are uncertainties regarding the process [5].
苏州纳芯微电子股份有限公司第三届董事会第二十一次会议决议公告
Shang Hai Zheng Quan Bao· 2025-11-18 18:54
Group 1 - The board of directors of Suzhou Naxin Microelectronics Co., Ltd. held its 21st meeting of the third session on November 18, 2025, with all 9 directors present, confirming the legality and validity of the meeting [2][4] - The board approved the proposal regarding the global offering of H shares and related arrangements for listing on the Hong Kong Stock Exchange, authorizing relevant personnel to handle specific matters related to the issuance and listing [2][5] - The board also approved the confirmation and commitment related to the H share issuance, ensuring compliance with relevant legal requirements for the prospectus [5][6] Group 2 - The board approved amendments to the internal governance system applicable after the H share issuance, allowing the chairman and authorized personnel to make necessary adjustments to the governance documents based on legal and regulatory requirements [7][8] - The revised internal governance system will take effect upon the listing of the H shares on the main board of the Hong Kong Stock Exchange, automatically invalidating the current governance system [7][8]
四川百利天恒药业股份有限公司 关于发行H股并上市的进展公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-13 05:10
Core Viewpoint - Sichuan Baili Tianheng Pharmaceutical Co., Ltd. is progressing with its plan to issue H-shares and list on the Hong Kong Stock Exchange, but has decided to delay the global offering and listing due to current market conditions [1][2]. Group 1 - The company has published its H-share prospectus and details regarding the public offering on November 7, 2025 [1]. - The subscription for the H-shares is limited to qualified overseas investors and certain domestic institutional investors as per relevant regulations [2]. - The company will not publish the announcement on domestic stock exchanges or media, and relevant information can be accessed on the Hong Kong Stock Exchange website [2].